Risk evaluation for the development of cervical intraepithelial neoplasia: Development and validation of risk-scoring schemes

Chien Hung Lee, Chiung Yu Peng, Ruei Nian Li, Yu Chieh Chen, Hsiu Ting Tsai, Yu Hsiu Hung, Te Fu Chan, Hsiao Ling Huang, Tai Cheng Lai, Ming Tsang Wu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cervical cancer screening guidelines do not comprehensively define what constitutes high risk. This study developed and validated simple risk-scoring schemes to improve Papanicolaou smear screening for women at high risk. Four cumulative risk score (CRS) schemes were derived respectively for the development of cervical intraepithelial neoplasia grade 1 (CIN1) and grade 2 or worse (CIN2+) using community-based case-control data (n = 1523). By calculating the area under the receiver operating characteristic (AU-ROC) curve, these schemes were validated in a Papanicolaou smear follow-up cohort (n = 967) and a hospital-based cytology screening population (n = 217). A high DNA load of high-risk human papillomavirus (HR-HPV) was the main predictor for CIN1 and CIN2+, although age, married status combined with the number of sexual partners, active and passive smoking and age at sexual debut also affected associated lesions. In the training set, only the HPV-testing-contained CIN2+ CRS scheme presented an excellent discrimination for identifying CIN2+ (AU-ROC = 0.866). Using a CRS cutoff value of 4 to identify CIN2+, the sensitivity and specificity of predicting CIN2+ for the 3- and 5-year follow-ups were 100% and 90.8%, and 83.3% and 90.4%, respectively, in the validation cohort. In the hospital-based validation population, the CRS scheme showed comparable discrimination for CIN2+ detection (sensitivity 88.2% and specificity 84.6%). Women with CRS ≥4 had a 5.4% and 9.1% of 3- and 5-year cumulative incidence, respectively, and a 40.5-fold hazard ratio of developing CIN2+. In conclusion, combined with HR-HPV testing and verified risk factors, a simple CRS scheme could effectively improve the implementation of CIN2+ screening. What's new? Cervical cancer is linked to various risk factors, including persistent infection with strains of high-risk human papillomavirus (HR-HPV). However, whether specific risk factor combinations place some women at greater risk than others is unclear. To find out, the authors of this study combined HR-HPV testing and verified risk factors to develop a cumulative risk score (CRS) scheme. Elevated HR-HPV DNA load was the primary predictor for cervical intraepithelial neoplasia grade 1 (CIN1) and grade 2 (CIN2), but other factors, such as marital status and smoking, also influenced risk-scoring. The CRS scheme was especially useful for CIN2+ screening.

Original languageEnglish
Pages (from-to)340-349
Number of pages10
JournalInternational Journal of Cancer
Volume136
Issue number2
DOIs
Publication statusPublished - Jan 15 2015
Externally publishedYes

Fingerprint

Cervical Intraepithelial Neoplasia
Papanicolaou Test
ROC Curve
Uterine Cervical Neoplasms
Sensitivity and Specificity
Tobacco Smoke Pollution
Sexual Partners
DNA
Marital Status

Keywords

  • cervical cancer screening
  • cervical intraepithelial neoplasia
  • human papillomavirus
  • risk evaluation
  • risk-scoring scheme

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Risk evaluation for the development of cervical intraepithelial neoplasia : Development and validation of risk-scoring schemes. / Lee, Chien Hung; Peng, Chiung Yu; Li, Ruei Nian; Chen, Yu Chieh; Tsai, Hsiu Ting; Hung, Yu Hsiu; Chan, Te Fu; Huang, Hsiao Ling; Lai, Tai Cheng; Wu, Ming Tsang.

In: International Journal of Cancer, Vol. 136, No. 2, 15.01.2015, p. 340-349.

Research output: Contribution to journalArticle

Lee, Chien Hung ; Peng, Chiung Yu ; Li, Ruei Nian ; Chen, Yu Chieh ; Tsai, Hsiu Ting ; Hung, Yu Hsiu ; Chan, Te Fu ; Huang, Hsiao Ling ; Lai, Tai Cheng ; Wu, Ming Tsang. / Risk evaluation for the development of cervical intraepithelial neoplasia : Development and validation of risk-scoring schemes. In: International Journal of Cancer. 2015 ; Vol. 136, No. 2. pp. 340-349.
@article{a14b27eedb3c4b3895b75fde90b5d433,
title = "Risk evaluation for the development of cervical intraepithelial neoplasia: Development and validation of risk-scoring schemes",
abstract = "Cervical cancer screening guidelines do not comprehensively define what constitutes high risk. This study developed and validated simple risk-scoring schemes to improve Papanicolaou smear screening for women at high risk. Four cumulative risk score (CRS) schemes were derived respectively for the development of cervical intraepithelial neoplasia grade 1 (CIN1) and grade 2 or worse (CIN2+) using community-based case-control data (n = 1523). By calculating the area under the receiver operating characteristic (AU-ROC) curve, these schemes were validated in a Papanicolaou smear follow-up cohort (n = 967) and a hospital-based cytology screening population (n = 217). A high DNA load of high-risk human papillomavirus (HR-HPV) was the main predictor for CIN1 and CIN2+, although age, married status combined with the number of sexual partners, active and passive smoking and age at sexual debut also affected associated lesions. In the training set, only the HPV-testing-contained CIN2+ CRS scheme presented an excellent discrimination for identifying CIN2+ (AU-ROC = 0.866). Using a CRS cutoff value of 4 to identify CIN2+, the sensitivity and specificity of predicting CIN2+ for the 3- and 5-year follow-ups were 100{\%} and 90.8{\%}, and 83.3{\%} and 90.4{\%}, respectively, in the validation cohort. In the hospital-based validation population, the CRS scheme showed comparable discrimination for CIN2+ detection (sensitivity 88.2{\%} and specificity 84.6{\%}). Women with CRS ≥4 had a 5.4{\%} and 9.1{\%} of 3- and 5-year cumulative incidence, respectively, and a 40.5-fold hazard ratio of developing CIN2+. In conclusion, combined with HR-HPV testing and verified risk factors, a simple CRS scheme could effectively improve the implementation of CIN2+ screening. What's new? Cervical cancer is linked to various risk factors, including persistent infection with strains of high-risk human papillomavirus (HR-HPV). However, whether specific risk factor combinations place some women at greater risk than others is unclear. To find out, the authors of this study combined HR-HPV testing and verified risk factors to develop a cumulative risk score (CRS) scheme. Elevated HR-HPV DNA load was the primary predictor for cervical intraepithelial neoplasia grade 1 (CIN1) and grade 2 (CIN2), but other factors, such as marital status and smoking, also influenced risk-scoring. The CRS scheme was especially useful for CIN2+ screening.",
keywords = "cervical cancer screening, cervical intraepithelial neoplasia, human papillomavirus, risk evaluation, risk-scoring scheme",
author = "Lee, {Chien Hung} and Peng, {Chiung Yu} and Li, {Ruei Nian} and Chen, {Yu Chieh} and Tsai, {Hsiu Ting} and Hung, {Yu Hsiu} and Chan, {Te Fu} and Huang, {Hsiao Ling} and Lai, {Tai Cheng} and Wu, {Ming Tsang}",
year = "2015",
month = "1",
day = "15",
doi = "10.1002/ijc.28982",
language = "English",
volume = "136",
pages = "340--349",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Risk evaluation for the development of cervical intraepithelial neoplasia

T2 - Development and validation of risk-scoring schemes

AU - Lee, Chien Hung

AU - Peng, Chiung Yu

AU - Li, Ruei Nian

AU - Chen, Yu Chieh

AU - Tsai, Hsiu Ting

AU - Hung, Yu Hsiu

AU - Chan, Te Fu

AU - Huang, Hsiao Ling

AU - Lai, Tai Cheng

AU - Wu, Ming Tsang

PY - 2015/1/15

Y1 - 2015/1/15

N2 - Cervical cancer screening guidelines do not comprehensively define what constitutes high risk. This study developed and validated simple risk-scoring schemes to improve Papanicolaou smear screening for women at high risk. Four cumulative risk score (CRS) schemes were derived respectively for the development of cervical intraepithelial neoplasia grade 1 (CIN1) and grade 2 or worse (CIN2+) using community-based case-control data (n = 1523). By calculating the area under the receiver operating characteristic (AU-ROC) curve, these schemes were validated in a Papanicolaou smear follow-up cohort (n = 967) and a hospital-based cytology screening population (n = 217). A high DNA load of high-risk human papillomavirus (HR-HPV) was the main predictor for CIN1 and CIN2+, although age, married status combined with the number of sexual partners, active and passive smoking and age at sexual debut also affected associated lesions. In the training set, only the HPV-testing-contained CIN2+ CRS scheme presented an excellent discrimination for identifying CIN2+ (AU-ROC = 0.866). Using a CRS cutoff value of 4 to identify CIN2+, the sensitivity and specificity of predicting CIN2+ for the 3- and 5-year follow-ups were 100% and 90.8%, and 83.3% and 90.4%, respectively, in the validation cohort. In the hospital-based validation population, the CRS scheme showed comparable discrimination for CIN2+ detection (sensitivity 88.2% and specificity 84.6%). Women with CRS ≥4 had a 5.4% and 9.1% of 3- and 5-year cumulative incidence, respectively, and a 40.5-fold hazard ratio of developing CIN2+. In conclusion, combined with HR-HPV testing and verified risk factors, a simple CRS scheme could effectively improve the implementation of CIN2+ screening. What's new? Cervical cancer is linked to various risk factors, including persistent infection with strains of high-risk human papillomavirus (HR-HPV). However, whether specific risk factor combinations place some women at greater risk than others is unclear. To find out, the authors of this study combined HR-HPV testing and verified risk factors to develop a cumulative risk score (CRS) scheme. Elevated HR-HPV DNA load was the primary predictor for cervical intraepithelial neoplasia grade 1 (CIN1) and grade 2 (CIN2), but other factors, such as marital status and smoking, also influenced risk-scoring. The CRS scheme was especially useful for CIN2+ screening.

AB - Cervical cancer screening guidelines do not comprehensively define what constitutes high risk. This study developed and validated simple risk-scoring schemes to improve Papanicolaou smear screening for women at high risk. Four cumulative risk score (CRS) schemes were derived respectively for the development of cervical intraepithelial neoplasia grade 1 (CIN1) and grade 2 or worse (CIN2+) using community-based case-control data (n = 1523). By calculating the area under the receiver operating characteristic (AU-ROC) curve, these schemes were validated in a Papanicolaou smear follow-up cohort (n = 967) and a hospital-based cytology screening population (n = 217). A high DNA load of high-risk human papillomavirus (HR-HPV) was the main predictor for CIN1 and CIN2+, although age, married status combined with the number of sexual partners, active and passive smoking and age at sexual debut also affected associated lesions. In the training set, only the HPV-testing-contained CIN2+ CRS scheme presented an excellent discrimination for identifying CIN2+ (AU-ROC = 0.866). Using a CRS cutoff value of 4 to identify CIN2+, the sensitivity and specificity of predicting CIN2+ for the 3- and 5-year follow-ups were 100% and 90.8%, and 83.3% and 90.4%, respectively, in the validation cohort. In the hospital-based validation population, the CRS scheme showed comparable discrimination for CIN2+ detection (sensitivity 88.2% and specificity 84.6%). Women with CRS ≥4 had a 5.4% and 9.1% of 3- and 5-year cumulative incidence, respectively, and a 40.5-fold hazard ratio of developing CIN2+. In conclusion, combined with HR-HPV testing and verified risk factors, a simple CRS scheme could effectively improve the implementation of CIN2+ screening. What's new? Cervical cancer is linked to various risk factors, including persistent infection with strains of high-risk human papillomavirus (HR-HPV). However, whether specific risk factor combinations place some women at greater risk than others is unclear. To find out, the authors of this study combined HR-HPV testing and verified risk factors to develop a cumulative risk score (CRS) scheme. Elevated HR-HPV DNA load was the primary predictor for cervical intraepithelial neoplasia grade 1 (CIN1) and grade 2 (CIN2), but other factors, such as marital status and smoking, also influenced risk-scoring. The CRS scheme was especially useful for CIN2+ screening.

KW - cervical cancer screening

KW - cervical intraepithelial neoplasia

KW - human papillomavirus

KW - risk evaluation

KW - risk-scoring scheme

UR - http://www.scopus.com/inward/record.url?scp=84922276267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922276267&partnerID=8YFLogxK

U2 - 10.1002/ijc.28982

DO - 10.1002/ijc.28982

M3 - Article

C2 - 24841989

AN - SCOPUS:84922276267

VL - 136

SP - 340

EP - 349

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -